Short access day 1 total inactive lever presses

Tags: Behavior · Cocaine · Short access

Project: p50_paul_meyer_2020

2 loci · 2 genes with independent associations · 2 total associated genes

Significant Loci

# Chr Start pos End pos # assoc genes # joint models Best TWAS P Best GWAS P Cond GWAS P Joint genes
1 chr1 79485178 80785451 1 1 4.69e-08 3.85e-02 4.95e-02 Zfp575
2 chr4 95890735 97085238 1 1 3.74e-14 2.21e-01 6.39e-14 Serbp1

Pleiotropic Associations

Trait Chi2 ratio # genes+ # genes++ % genes++ Corr Corr P Genes
BMI without tail 3.89 2 0 0 0 1e+00 Serbp1 Zfp575
Left kidney weight 2.5 1 0 0 0 1e+00 Zfp575
Right kidney weight 5.42 2 0 0 0 1e+00 Serbp1 Zfp575
Tail length 2.64 2 0 0 0 1e+00 Serbp1 Zfp575
Length with tail 3.13 1 0 0 0 1e+00 Serbp1
Length without tail 4.31 1 0 0 0 1e+00 Zfp575
Liver weight, left 7.79 1 0 0 0 1e+00 Serbp1
Parametrial fat weight 2.76 1 0 0 0 1e+00 Zfp575
Retroperitoneal fat weight 3.15 1 0 0 0 1e+00 Serbp1
Intraocular pressure 5.48 1 0 0 0 1e+00 Serbp1
Patch foraging indifference point AUC 12.17 1 0 0 0 1e+00 Serbp1
Patch foraging total patch changes 18 sec 10.94 1 0 0 0 1e+00 Serbp1
Patch foraging total patch changes 24 sec 4.53 1 0 0 0 1e+00 Zfp575
Patch foraging total patch changes 6 sec 7.52 1 0 0 0 1e+00 Serbp1
Patch foraging water rate 0 sec 6.51 1 0 0 0 1e+00 Serbp1
Patch foraging water rate 12 sec 4.1 1 0 0 0 1e+00 Serbp1
Patch foraging water rate 18 sec 5.55 1 0 0 0 1e+00 Serbp1
Patch foraging water rate 6 sec 4.97 1 0 0 0 1e+00 Zfp575
Locomotor activity 3.36 1 0 0 0 1e+00 Serbp1
Light reinforcement 1 8.51 1 0 0 0 1e+00 Serbp1
Light reinforcement 2 7.05 1 0 0 0 1e+00 Serbp1
Reaction time number correct 4.8 1 0 0 0 1e+00 Zfp575
Reaction time trials correct on left 4.8 1 0 0 0 1e+00 Zfp575
Reaction time trials on left 4.9 1 0 0 0 1e+00 Zfp575
Reaction time mean AUC 4.32 1 0 0 0 1e+00 Serbp1
Reaction time omissions 4.8 1 0 0 0 1e+00 Serbp1
Reaction time premature initiations 6.63 1 0 0 0 1e+00 Serbp1
Reaction time trials completed 4.9 1 0 0 0 1e+00 Zfp575
Reaction time trials AUC 4.63 1 0 0 0 1e+00 Zfp575
Social responses 4.22 1 0 0 0 1e+00 Zfp575
Social time 4.57 1 0 0 0 1e+00 Serbp1
Conditioned reinforcement - actives 5.59 1 0 0 0 1e+00 Zfp575
Conditioned reinforcement - inactives 4.8 1 0 0 0 1e+00 Zfp575
Conditioned locomotion 6.92 2 0 0 0 1e+00 Serbp1 Zfp575
Intermitt. access day 15 inactive lever presses 5.48 1 0 0 0 1e+00 Serbp1
Intermittent access day 1 total infusions 11.42 1 0 0 0 1e+00 Serbp1
Intermittent access day 15 total infusions 12.79 2 0 0 0 1e+00 Serbp1 Zfp575
Intermittent access terminal intake (last 3 days) 23.43 2 1 50 0 1e+00 Serbp1 Zfp575
Intermittent access total infusions 11.53 2 0 0 0 1e+00 Serbp1 Zfp575
Intermittent access day 1 locomotion 5.4 1 0 0 0 1e+00 Zfp575
Intermittent access total locomotion 11.21 1 0 0 0 1e+00 Zfp575
Intermittent access standard deviation 7.36 2 0 0 0 1e+00 Serbp1 Zfp575
Lifetime Intake 10.1 2 0 0 0 1e+00 Serbp1 Zfp575
Incentive Sensitization - Responses 22.65 1 0 0 0 1e+00 Zfp575
Incentive Sensitization - Breakpoint 27 1 1 50 0 1e+00 Zfp575
Progressive ratio test 1 active lever presses 22.83 1 0 0 0 1e+00 Serbp1
Progressive ratio test 1 breakpoint 29.2 1 1 50 0 1e+00 Serbp1
Progressive ratio test 1 inactive lever presses 11.37 1 0 0 0 1e+00 Serbp1
Progressive ratio test 2 active lever presses 9.25 2 0 0 0 1e+00 Serbp1 Zfp575
Progressive ratio test 2 breakpoint 9.78 2 0 0 0 1e+00 Serbp1 Zfp575
Progressive ratio test 2 inactive lever presses 6.34 2 0 0 0 1e+00 Serbp1 Zfp575
Total sessions with >9 infusions 25.9 2 1 50 0 1e+00 Serbp1 Zfp575
Short access day 10 total inactive lever presses 35.25 1 1 50 0 1e+00 Serbp1
Short access day 1 total infusions 12.06 2 0 0 0 1e+00 Serbp1 Zfp575
Short access total infusions 9.9 1 0 0 0 1e+00 Serbp1
Short access day 1 locomotion 8.45 1 0 0 0 1e+00 Serbp1
Compulsive drug intake 13.27 2 0 0 0 1e+00 Serbp1 Zfp575
One hour access (0.3 mA shock) 46.44 1 1 50 0 1e+00 Zfp575
One hour access (shock baseline) 26 1 1 50 0 1e+00 Zfp575
Number of responses in last shaping day 10.18 2 0 0 0 1e+00 Serbp1 Zfp575
Locomotion velocity, session 7 6.12 1 0 0 0 1e+00 Serbp1
Distance traveled before self-admin 16.57 1 0 0 0 1e+00 Zfp575
Distance traveled after self-admin 9.14 1 0 0 0 1e+00 Zfp575
Delta time in closed arm before/after self-admin 10.9 1 0 0 0 1e+00 Serbp1
Delta time in open arm before/after self-admin 23.57 1 0 0 0 1e+00 Serbp1
Diff in mean of infusions in LGA sessions 18.85 1 0 0 0 1e+00 Serbp1
Extinction: sum of active levers before priming 17.14 1 0 0 0 1e+00 Zfp575
Active lever presses in extinction session 6 18.99 2 1 50 0 1e+00 Serbp1 Zfp575
Time in closed arm before self-admin 13.02 1 0 0 0 1e+00 Serbp1
Time in closed arm after self-admin 6.26 2 0 0 0 1e+00 Serbp1 Zfp575
Time in open arm before self-admin 21.1 1 0 0 0 1e+00 Zfp575
Sum of active levers in priming session hrs 5-6 8.73 1 0 0 0 1e+00 Serbp1
Time to tail flick, vehicle, before self-admin 14.83 1 0 0 0 1e+00 Serbp1
Time to tail flick, vehicle, after self-admin 29.99 2 1 50 0 1e+00 Serbp1 Zfp575
Time to tail flick, test, before self-admin 8.16 2 0 0 0 1e+00 Serbp1 Zfp575
Delta time to tail flick, vehicle, before/after SA 9.85 1 0 0 0 1e+00 Serbp1
Ambulatory time before self-admin 8.91 1 0 0 0 1e+00 Zfp575
Ambulatory time after self-admin 12.12 2 0 0 0 1e+00 Serbp1 Zfp575
Total heroin consumption 10.71 1 0 0 0 1e+00 Serbp1
Change in fecal boli incidents, locomotor task 9.76 2 0 0 0 1e+00 Serbp1 Zfp575
Rest time, locomotor task time 1 16.73 1 0 0 0 1e+00 Serbp1
Vertical activity count, locomotor time 1 12.65 2 0 0 0 1e+00 Serbp1 Zfp575
Vertical activity count, locomotor time 2 6.77 1 0 0 0 1e+00 Serbp1
Weight adjusted by age 15.78 1 0 0 0 1e+00 Zfp575
Seeking ratio, delayed vs. immediate footshock 8.42 2 0 0 0 1e+00 Serbp1 Zfp575
Locomotion in novel chamber 6.51 1 0 0 0 1e+00 Zfp575
Locomotion in novel chamber post-restriction 18.24 1 0 0 0 1e+00 Serbp1
Food seeking constrained by brief footshock 11.04 1 0 0 0 1e+00 Zfp575
Latency to leave start box in cocaine runway, M 14.7 1 0 0 0 1e+00 Zfp575
Sr content in liver 6.24 1 0 0 0 1e+00 Zfp575

Associations by panel

Tissue RNA modality # hits % hits/tests Avg chisq
Adipose alternative polyA 0 0 1.03
Adipose alternative TSS 0 0 1.1
Adipose gene expression 0 0 1.11
Adipose isoform ratio 0 0 1.08
Adipose intron excision ratio 0 0 1.14
Adipose mRNA stability 0 0 1.09
BLA alternative polyA 0 0 1.17
BLA alternative TSS 0 0 1.07
BLA gene expression 0 0 1.13
BLA isoform ratio 0 0 1.11
BLA intron excision ratio 0 0 1.11
BLA mRNA stability 0 0 1.12
Brain alternative polyA 0 0 1.11
Brain alternative TSS 0 0 1.12
Brain gene expression 0 0 1.12
Brain isoform ratio 0 0 1.16
Brain intron excision ratio 0 0 1.1
Brain mRNA stability 0 0 1.11
Eye alternative polyA 0 0 1.4
Eye alternative TSS 0 0 0.96
Eye gene expression 0 0 1.25
Eye isoform ratio 0 0 1.11
Eye intron excision ratio 0 0 1.04
Eye mRNA stability 0 0 1.17
IL alternative polyA 0 0 1.24
IL alternative TSS 0 0 1
IL gene expression 0 0 1.12
IL isoform ratio 0 0 1.16
IL intron excision ratio 0 0 1.07
IL mRNA stability 0 0 1.19
LHb alternative polyA 0 0 1.15
LHb alternative TSS 0 0 1.21
LHb gene expression 0 0 1.12
LHb isoform ratio 0 0 1.18
LHb intron excision ratio 0 0 1.11
LHb mRNA stability 0 0 1.22
Liver alternative polyA 0 0 1.06
Liver alternative TSS 0 0 1.11
Liver gene expression 0 0 1.13
Liver isoform ratio 1 0 1.18
Liver intron excision ratio 0 0 1.05
Liver mRNA stability 0 0 1.13
NAcc alternative polyA 0 0 1.11
NAcc alternative TSS 0 0 1.12
NAcc gene expression 0 0 1.14
NAcc isoform ratio 0 0 1.13
NAcc intron excision ratio 0 0 1.08
NAcc mRNA stability 0 0 1.12
OFC alternative polyA 0 0 1.2
OFC alternative TSS 0 0 1.06
OFC gene expression 0 0 1.1
OFC isoform ratio 0 0 1.13
OFC intron excision ratio 0 0 1.06
OFC mRNA stability 0 0 1.14
PL alternative polyA 0 0 1.14
PL alternative TSS 0 0 1.07
PL gene expression 0 0 1.12
PL isoform ratio 0 0 1.17
PL intron excision ratio 0 0 1.13
PL mRNA stability 1 0 1.17
pVTA alternative polyA 0 0 1.15
pVTA alternative TSS 0 0 1.12
pVTA gene expression 0 0 1.14
pVTA isoform ratio 0 0 1.17
pVTA intron excision ratio 0 0 1.1
pVTA mRNA stability 0 0 1.2
RMTg alternative polyA 0 0 1.13
RMTg alternative TSS 0 0 1
RMTg gene expression 0 0 1.15
RMTg isoform ratio 0 0 1.07
RMTg intron excision ratio 0 0 1.07
RMTg mRNA stability 0 0 1.2